The amino acid sequence RGD (arginine-glycine-aspartic acid) is highly conserved in the VPI protein of foot-and-mouth disease virus (FMDV), despite being situated in the immunodominant hypervariable region between amino acids 135 and 160. RGDcontaining proteins are known to be important in promoting cell attachment in several different systems, and we report here that synthetic peptides containing this sequence are able to inhibit attachment of the virus to baby hamster kidney (BHK) cells. Inhibition was dose-dependent and could be reversed on removal of the peptide. A synthetic peptide corresponding to a portion of the same hypervariable region but not containing the RGD sequence did not inhibit virus attachment under the same conditions. Antibody against the RGD region of VPI blocked attachment of the virus to BHK cells, and neutralizing monoclonal antibodies, which neutralize virus by preventing cell attachment, were blocked by RGD-containing peptides from binding virus in an ELISA test. Cleavage of the C-terminal region of virus VP1 in situ with proteolytic enzymes reduced cell attachment, and antiserum against a peptide corresponding to this region was also able to inhibit attachment of virus to BHK cells. These results indicate that the amino acid sequence RGD at positions 145 to 147 and amino acids from the C-terminal region of VP1 (positions 203 to 213) contribute to the cell attachment site on FMDV for BHK cells.
INTRODUCTION
Following the initial demonstration that the amino acid sequence RGD (arginine-glycineaspartic acid) is responsible for the cell attachment-promoting activity of the extracellular glycoprotein fibronectin (Pierschbacher & Ruoslahti, 1984a) , this sequence has been shown to have the same activity in a number of other proteins. Examples are vitronectin (Hayman et al., 1985) , discoidin I (Springer et al., 1984; Gabius et al., 1985) , fibrinogen (Gartner & Bennett, 1985; Plow et al., 1985) , type I collagen (Dedhar et al., 1987) , osteopontin (Oldberg et al., 1986) , the complement protein fragment C3bi (Wright et al., 1987) , von Willebrand factor (Haverstick et al., 1985) and the phage receptor of Escherichia coli, which binds mammalian cells in vitro (Pytela et al., 1985) .
Attachment to RGD-containing peptides has been demonstrated for endothelial, epithelial and fibroblastic cell lines (Hayman et al., 1985) , including baby hamster kidney (BHK) cells (Akiyama & Yamada, 1985) ,which have been used in this study. Attachment is mediated via a group of related receptors, termed integrins (Tamkun et al., 1986) , which, despite interacting with a common ligand, show specificity for different RGD-containing proteins (for a review see .
Foot-and-mouth disease virus (FMDV) belongs to the aphthovirus genus of the family Picornaviridae. It consists of a positive sense ssRNA molecule enclosed in a protein coat containing 60 copies of each of four proteins, VP1 to 4. The amino acid sequence RGD, first noted by Geysen et aL (1985) , occurs at positions 145 to 147 of VP1. This sequence is highly conserved in the seven FMDV serotypes with, to our knowledge, only one exception, strain Alo61, which has the sequence RSGD (arginine-serine-glycine-aspartic acid) in the equivalent position. The major antigenic sites on FMDV also occur in VP1, the most important being the hypervariable region between amino acids 135 and 160, which includes the RGD sequence (Strohmaier et al., 1982; Bittle et al., 1982) . An additional antigenic site is situated at the C terminus of VP1 (Strohmaier et al., 1982) . Hydrolysis of FMDV with trypsin cleaves VP1 in both of these regions, leading to a dramatic fall in infectivity (103-to 104-fold) which has been attributed to an inability of the treated virus to attach to cells, presumably through disruption of the attachment site on the virus (Wild & Brown, 1967; Wild et al., 1969; Strohmaier et al., 1982) .
This evidence, combined with the noted importance of RGD in other proteins, led us to investigate whether it is responsible for attachment of the virus to susceptible cells.
METHODS
Virus. FMDV strains A1061, OIBFS 1860 and O1K were grown on BHK-21 cell monolayers, radiolabelled with
[35S]methionine, and purified as previously described by Brown & Cartwright (1963) .
Enzyme cleavage of virus. Sucrose density gradient-purified radiolabelled virus was incubated either (i) for 4 h at 37 °C with the proteolytic enzyme endoproteinase Lys-C (Boehringer Mannheim) at a virus protein :enzyme ratio of 1 : 100 (w/w), or (ii) for 3 h at 37 °C with the proteolytic enzyme mouse submaxillary gland protease (MSGP; Sigma) at a virus protein : enzyme ration of 1 : 50 (w/w). Control virus was incubated in a similar manner, in the absence of enzyme. After incubation, samples were diluted in TN buffer (0.1 M-Tris-HCI, 0.14 M-NaC1, pH 7-6) and repurified on a second sucrose gradient. Peak fractions were collected and an aliquot was prepared for PAGE.
Gel electrophoresis. Radiolabelled virus samples were boiled in disruption buffer and loaded onto discontinuous 12.5~ SDS-polyacrylamide gels (Laemmli, 1970) ; 7 M-urea was incorporated in the gels used to analyse virus strain A~061. Gels were electrophoresed for 4 to 5 h at 150 V, fixed, treated with Amplify (Amersham) and dried. Protein bands were visualized by autoradiography.
Synthetic peptides. Peptides were synthesized by a solid-phase method on a packed column of kieselguhrsupported polyamide resin under pumped-flow conditions. FMOC (N-9-fluorenyl-methoxycarbonyl)-protected amino acids were used and side-chain functionalities were protected during synthesis with the following groups: Arg (4-methoxy-2,3,6-trimethylphenylsulphonyl), Asp (tert-butyl), Ser (tert-butyl), Thr (tert-butyl), Lys (trifluoroacetic acid), Cys (acetamidomethyl).
Initial resin attachment was performed by dimethylaminopyrimidine-mediated acylation using symmetrical anhydrides. After removal of FMOC with piperidine, subsequent amino acids were coupled via their pre-formed hydroxybenzotriazole esters. The peptides were detached from the polymer support and deprotected using 95 trifluoroacetic acid. Following gel filtration, the lyophilized peptides were characterized by HPLC, TLC, elementary microanalysis, fast atom bombardment mass spectrometry and amino acid analysis.
Virus attachment assay
Peptide blocking. BHK cell monolayers were grown in microtitre wells, reaching a concentration of approx.
10 s cells per well. Peptide (15 ~tl), diluted in phosphate-buffered saline (PBS) pH 7-6, was added to cell monolayers which had been previously washed in PBS. Monolayers were incubated for 45 min at 4 °C before the addition of 10 ~tl of radiolabelled virus diluted in PBS. Virus dilution was adjusted so that the virus :cell ratio was below 2 x 104 : 1 to avoid saturation of receptor sites (Baxt & Bachrach, 1980) . Virus was allowed to attach to cells for a further 45 min before removal of the supernatant, and a single washing of the cell sheet with PBS. The supernatant and washings were then combined, adsorbed onto a glass fibre disc (Whatman GF/A), dried and immersed in scintillation fluid (Betafluor, National Diagnostics) prior to counting in a Beckman LS 1801 liquid scintillation counter. The BHK cell monolayers were dissolved in 98~ formic acid (BDH), transferred to glass fibre discs, dried, and counted as above. The percentage of virus attached to cells was then calculated by dividing the counts in the cellular fraction by the total. In experiments where the reversibility of peptide blocking was to be tested, virus was allowed to attach to cells which had been incubated with peptide, as above, and the supernatant was removed for counting. The cell sheet was then washed extensively in PBS, to remove the peptide, before repeating the virus attachment assay. By comparing the counts in the supernatants in the presence of peptide, and after removal of peptide, with the total counts that had been added, the percentage attachment of virus in each case could be calculated. The peptide blocking assays were carried out at 4 °C to minimize the possibility of internalization of peptides by the cells, while still maintaining conditions under which the virus attaches normally (Baxt & Bachrach, 1980) .
Antibody blocking.
The ability of the virus to attach to susceptible cells in the presence of antibody was tested by one of two methods. (i) One-hundred gl of purified radiolabelled virus was added to an equal volume of a dilution series of antibody in Eagle's MEM. After incubation at 37 °C for 30 rain, each mixture was transferred to a 25 cm 2 flask containing a BHK cell monolayer which had been extensively washed with serum-free medium. The flasks were incubated at 37 °C on a rocker for a further 1 h before removal of supernatant and two washes of the cell sheet. Aliquots of the combined supernatant and washings and the dissolved cell sheet were counted as described.
(ii) Purified labelled virus was added to 300 gl samples of a dilution series of antibody in Eppendorf tubes. The mixtures were incubated at 37 °C for 30 min before the addition of 1 × 107 EDTA-dispersed BHK monolayer cells resuspended in Eagle's MEM. Incubation was continued on a rotary platform at 37 °C for 1 h before pelleting of the cells and counting of the supernatants as before.
Enzyme-cleaved virus. Dispersed BHK cell monolayers were resuspended in PBS, 1 ~ bovine serum, pH 7.6, at a concentration of approx. 1 x 107 cells per ml. Aliquots (1 ml) were dispensed into Eppendorf tubes. A subsaturating amount of virus, or enzyme-cleaved virus, was added to each tube, which was then agitated at 4 °C for the required time. Cells were pelleted in an Eppendorf centrifuge, washed twice in PBS and counted as previously described. The supernatant and washings were combined and counted as previously described. The percentage of virus attached to cells was then calculated by dividing the counts in the cellular fraction by the total.
Antigen inhibition sandwich ELISA. Purified virus at a concentration of 2 gg/ml was trapped on flexible PVC microplates using a partially purified specific rabbit IgG capture antibody. Serial doubling dilutions of competitor peptides in PBS A, 0-05~ Tween 20, 1~ o bovine serum albumin were mixed with an equal volume of a predetermined dilution of mouse monoclonal antibody or guinea-pig polyclonal antiserum and maintained at 4 °C overnight. A quantity (50 gl) of the mixture was then added to duplicate wells of the washed dried microplates containing captured virus. Following incubation for 1 h at 37 °C the plates were washed and dried and 50 gl per well of peroxidase-labelled rabbit IgG (1/2000; Miles Laboratories) was added. After further incubation at 37 °C for 1 h and rewashing, each well received 50 gl of ophenylenediamine-peroxide substrate in citrate buffer. Colour development was stopped with 12-5 ~ sulphuric acid, and the absorbance values were read on a Titertek Multiskan spectrophotometer at 492 nm.
RESULTS

Peptide inhibition of virus-cell attachment
Five synthetic peptides comprising the RGD sequence of virus strain O1BFS 1860 VP1 at positions 145 to 147, with varying amounts of the flanking sequence, were assessed for inhibition of virus attachment to BHK cells. In addition, a peptide homologous to a region of Sindbis virus coat protein, containing RGD but having a different flanking sequence, was also tested. Sindbis virus, an alphavirus, has some structural similarities to picornaviruses (Fuller et al., 1987) . A peptide corresponding to part of the hypervariable region of VP 1 between positions 152 and 160, and therefore not containing RGD, was selected as a control (Table 1) .
For virus strain O1BFS 1860, attachment to cells in the absence of peptide reached 56~ in 45 min. Attachment was not significantly affected by preincubation with the control peptide ( Fig. 1 ). Of the sequences tested, peptide 1 comprising RGD only had the least inhibitory effect, reducing attachment by a maximum of 399/o (Fig. 1 a) . Peptides 2 to 5 inhibited attachment by between 61 and 63 ~ at their highest concentrations ( Fig. I b to e). This increased inhibition was apparently conferred by the sequence flanking RGD, although there were no obvious constraints on flanking sequence composition. [The non-homologous Sindbis peptide (peptide 2) inhibited attachment to the same degree as a homologous peptide of the same length (peptide 3), and in the case of peptide 5, the addition of a single leucine residue to the C-terminal side of RGD also increased inhibition.] The longest peptide (peptide 6) corresponding to amino acids 141 to 160 of VP1, and therefore containing considerable flanking sequence to RGD, failed to inhibit attachment of virus to cells. The reason for this is unclear, but it may be that the longer peptide has a preferred conformation with a low affinity for the receptor, and hence is easily displaced by virus.
The second FMDV strain analysed was Alo61, which has the sequence RSGD at positions 144 to 147 of VP1, representing an exception to the RGD norm. The same set of peptides was used to inhibit attachment as had been used for strain O1BFS 1860 ( Table 1 ), so that in this case the peptides were non-homologous with virus both in their flanking sequence and in the RGD sequence itself. Attachment to cells in the absence of peptide reached 34 ~ after 45 min, and this was not significantly affected by preincubation with the control peptide (Fig. 2) . Preincubation with peptides 1 to 5, however, resulted in significant inhibition of attachment, despite their nonhomology with virus sequence. Peptide 1 inhibited attachment by a maximum of 65 ~o and peptides 2 to 5 by 72 to 75 ~o at their highest concentrations. The levels of inhibition were higher than those obtained with virus strain O1BFS 1860, especially in the case of peptide 1, the RGD tripeptide. This was perhaps a reflection of differences in affinity for receptors. Once again peptide 6 failed to inhibit attachment. To test the possibility that inhibition of attachment was due to a toxic effect on the cells by the peptides, the reversibility ofpeptide inhibition was assessed. In this experiment the attachment of virus to cells was measured first after preincubation with the peptide, and second after washing the cells to remove the peptide. After preincubation with peptides 1 to 5, virus attachment was significantly depressed when compared to controls, but on removal of the peptides attachment levels returned to those of the controls, demonstrating that there was no toxic effect of the peptides on BHK cells (Table 2) .
These results demonstrate the ability of the tripeptide RGD to inhibit attachment of two strains of FMDV to BHK cells. One of the strains, O1BFS 1860, contains the sequence RGD in a major antigenic site, while the other, Alo61, has a similar sequence, RSGD, at this position. Peptide inhibition was enhanced by the incorporation of some flanking sequence to RGD; however, there was no absolute requirement for homology of the flanking sequence with the corresponding virus sequence. The possibility of a non-specific inhibitory effect of peptides seems unlikely, as the control peptide and peptide 6 both failed to inhibit attachment. Furthermore, in experiments in which 1 to 5 ~ serum was incorporated in the buffer to negate any effects due to peptide concentration alone, the two peptides tested, 4 and 5, both proved fully inhibitory (G. Fox, unpublished results).
Antibody blocking attachment assay
In another approach to the identification of the FMDV cell attachment site, three neutralizing monoclonal antibodies were tested for their ability to inhibit attachment of virus strain O1BFS 1860 to BHK cells. All were able to inhibit attachment in a dose-dependent manner, whereas two non-neutralizing monoclonal antibodies failed to inhibit attachment * Radiolabelled virus was allowed to attach at 4 °C for 45 rain to cells which had been preincubated with 15 mM peptide. The supernatant was removed for counting. The cell sheet was washed extensively to remove peplide. A second aliquot of virus was allowed to attach to the cells for a further 45 rain before removal of the second supernatant for counting. By comparing the counts in each supernatant with the total counts added the percentage attachment of virus in each case could be calculated. It was assumed that virus attachment was not reversible under these conditions. The total virus added was subsaturating.
significantly (Fig. 3) . The neutralizing monoclonal antibodies have been found to bind to amino acids from both the RGD region and the C-terminal region of VP 1 (Parry et al., 1985) , implying proximity of the two areas on the virus surface. Moreover, polyclonal antisera raised against peptides 141-160-C (the RGD region) and 200-213-C (the C-terminal region) of V P 1 were both able to block virus attachment (Fig. 3) . These results imply that the RGD sequence and the Cterminal region of VP1 both contribute to the attachment of FMDV to BHK cells.
To assess the specificity of binding of the neutralizing monoclonal antibodies, a competition ELISA was performed in which the ability of RGD-containing peptides to inhibit the binding of the monoclonal antibodies to virus was assessed (Fig. 4) . Binding was inhibited in all cases to levels i> 86~ by peptides 1 and 3, both of which are homologous with virus sequence. Peptide 2, comprising RGD with the heterologous Sindbis virus coat protein flanking sequence, inhibited attachment to a much lower level with two of the sera, and was only effective at high concentrations with the third.
These results emphasize the importance of RGD in the binding of these antibodies and also show the importance of the flanking sequence for antibody specificity. Thus, although the flanking sequence composition may not be critical in attachment of virus to cells, it forms part of the antibody footprint in this region, and hence is very much involved in the immune response to the virus. It cannot be ruled out, however, that inhibition of attachment by these antibodies on binding to virus is mediated via an allosteric effect on a distal attachment site not connected with RGD.
Cell attachment of enzyme-cleaved virus
It has long been established that cleavage of FMDV with trypsin, which removes amino acids from the RGD region and the C-terminal region of VP1, abolishes cell attachment (Wild & Brown, 1967; Wild et al., 1969; Strohmaier et al., 1982) . Using the lysine-specific enzyme endoproteinase Lys-C we have been able to cleave the VP1 of virus strain A1061 in situ in the Cterminal region only. The results show that cleavage in this region alone abolished cell attachment (Fig. 5) . A similar cleavage of virus strain O1K partially inhibited cell attachment (Fig. 6) . These data support a role for the C-terminal region of VP 1 in the attachment of FMDV to susceptible cells. The C-terminal cleavage site of endoproteinase Lys-C has previously been determined in the case of strain O1K to be at position 202 of VP1 (Strohmaier et al., 1982) . With reference to this, and by PAGE analysis of the cleavage fragments, it is probable that strain A1061 is also cleaved at position 202 (Fig. 5) . In both cases amino acids 203 to 213 were lost from the virus. The simultaneous cleavage at position 154 of strain O1K resulted in no loss of amino acids (Fig. 6 ), but the possibility that this cleavage, and not the removal of the C-terminal amino acids, was responsible for the reduction in cell attachment in this case, cannot be eliminated. Using the arginine-specific enzyme MSGP which cleaves the VP1 of strain O1K at position 145 only (the R of RGD), cell attachment was partially inhibited (Fig. 6 ). This cleavage resulted in no loss of amino acids from the virus, but presumably disrupted the RGD site sufficiently to , and with reference to published cleavage patterns (Strohmaier et al., 1982) it was concluded that the most likely cleavage site is K 202 (T).
affect cell attachment. It is unlikely that failure to attach to cells is due to a non-specific 'distortion' of virus on proteolytic cleavage as cleavage of the virus in other regions of VP 1 did not greatly affect cell attachment (Cavanagh et al., 1977) . Our results are somewhat at variance with those of Strohmaier et al. (1982) who could detect no significant loss of virus infectivity in a plaque assay after cleavage of strain O I K with either enzyme. This discrepancy may, however, reflect a difference in sensitivity between attachment and infectivity assays rather than a qualitative difference. For example, a reduction in cell attachment of 50 ~ is equivalent to a 10°'3-fold fall in infectivity, which is generally considered to be within the limits of experimental error in the plaque assay.
Virus strain O~K was selected for our enzyme studies as it remains the only strain in which enzyme cleavage sites have been fully determined (Strohmaier et al., 1982) . There are no sequence differences between strain O t K and O~BFS 1860 (used in the serology and peptide inhibition studies) in the R G D and C-terminal regions of VP1. Hence we consider that the showing the published cleavage sites for the lysine-specific endoproteinase Lys-C (A) and the arginine-specific MSGP (z~x) (Strohmaier et aL, 1982) .
conclusions drawn apply equally to virus strain 01BFS. It was therefore not felt useful to extend the study to situations in which enzyme cleavage sites could not be accurately predicted.
DISCUSSION
The amino acid sequence R G D is responsible for the cell attachment-promoting activity of a range of important biological molecules. In most cases perturbation of the R G D sequence in active peptides has led to a loss of activity (Pierschbacher & Ruoslahti, 1984a, b; Yamada & Kennedy, 1985) . In some cases, however, activity has been shown in related peptides, for example Gly-Arg-Gly-Glu-Ser with a conservative substitution of the aspartic acid residue, ArgGlu-Asp-Val with a less conservative glutamic acid substitution for glycine, and even the reverse sequence Ser-Asp-Gly-Arg (Yamada & Kennedy, 1985; Humphries et al., 1986) . In another study the peptide Tyr-Ile-Gly-Ser-Arg derived from laminin was shown to inhibit adhesion of metastatic melanoma cells to a greater extent than Arg-Gly-Asp-Ser (Iwamoto et al., 1987) . Interestingly the reverse sequence Arg-Ser-Gly-Ile-Tyr which has a tripeptide sequence in common with the FMDV strain Ai061 (RSGD), was also active. Our results implicate RGD in the attachment of FMDV to BHK cells, and in the one case in which RGD is not present the related sequence RSGD is probably responsible for this function. Thus it may be that there is some latitude in attachment site composition, although this might reflect affinities for different receptors.
No receptor has yet been identified for FMDV, but competition studies have shown only a partial reciprocal inhibition of attachment between different strains even with the common RGD sequence (Sekiguchi et al., 1982; Baxt & Bachrach, 1980) . The most likely explanation for this is that there is more than one receptor for FMDV on BHK cells; thus different strains of virus may have some common and some unique receptors. In the particular case of strain Alo61 it has been shown that trypsin hydrolyses 40 to 50 ~ of its receptors on BHK cells compared with 100~ hydrolysis of receptors for an O1 strain (Cavanagh, 1976) , and we could demonstrate little or no reciprocal inhibition of attachment between the two strains (G. Fox, unpublished results). Thus it may be that strain A1061 has evolved to attach to a minor subgroup of the FMDV receptors. Differences in the relative affinity between peptide and the two virus strains for their respective receptors might also explain the greater levels of attachment inhibition seen with strain A1061. The observed differences between strains of FMDV imply that members of the putative 'receptor group' can differentiate between different RGD-containing molecules. Such a property is demonstrated by the integrins, where fibronectin and vitronectin receptors are both blocked by RGD-containing peptides, and yet neither binds the heterologous protein, despite sequence homology across the RGD attachment site (Pytela et al., 1985) .
It is implicit, both in the work with integrins and in our study, that other factors contribute to attachment. In some instances extension or modification of the RGD flanking sequence enhanced activity (Pierschbacher & Ruoslahti, 1984a Ruggeri et al., 1986) . In our study we also found some enhancement of peptide activity on inclusion of RGD flanking sequence, but the lack of specific requirements in the flanking sequence led us to conclude that it does not contribute directly to attachment in this case. Indeed a literature survey of 16 subtype sequences covering the seven serotypes of FMDV revealed seven different amino acids at the position immediately to the N-terminal side of RGD, and six at the position immediately to the Cterminal side. Such a large variation is unlikely to reflect a specific contribution from these regions, even allowing for more than one virus receptor. Our results show, however, that the amino acids flanking the RGD sequence do have a considerable effect on immune recognition of the RGD site. Another possibility is that amino acids which are removed from RGD in the primary sequence, but constitute part of the same 'site' in the tertiary structure, contribute to the attachment site. Two lines of evidence have implicated amino acids from the C-terminal region of VP 1 in this role. Monoclonal antibodies, which neutralize virus by inhibiting cell attachment, were themselves inhibited, not only by RGD-containing peptides, but also by peptides from the C-terminal region of VP1 (Parry et al., 1985) , and antisera against peptides from this region blocked virus attachment to cells. Also the enzymic cleavage of this region abolished cell attachment, implying that its contribution is not merely through a steric effect on the RGD site. Predictive models of VP 1 structure have placed the RGD region and the C-terminal region of VP 1 in close proximity on the virus surface (B. H. Nicholson, personal communication; Morrell et al., 1987) , but whether amino acids from the C-terminal region contribute directly to attachment, or indirectly by providing conformational support for the RGD site, is not clear. In either case variations in this region may be responsible for the different receptor specificities amongst FMDV strains. A possible parallel for this occurs in the case of fibrinogen, where an attachment sequence, separated from RGD in the primary sequence, has been shown to compete with RGD-containing peptides for binding to a platelet receptor (Lam et al., 1987; Santoro & Lawing, 1987) . It is not clear whether the two sequences bind to overlapping or conformationally interdependent sites (Santoro & Lawing, 1987) . In fact, this sequence, HHLGGAKQAGDV, derived from the C-terminus of the fibrinogen y chain, has some similarity with the VPI C-terminal sequence of FMDV, KQKIIAPAKQLL. (Homologous residues and those where there is a conservative change are shown in bold type. The FMDV sequence is derived from strain A1o61.) Extraneous cofactors also contribute to RGD attachment, e.g. both FMDV attachment to cells and integrin receptor activity are dependent on divalent cations Brown et at., 1962) , and there is evidence that disialogangliosides contribute to the attachment of melanoma cells to RGD-containing substrates (Cheresh et al., 1986 (Cheresh et al., , 1987 . Thus, whereas RGD is central to attachment, other factors clearly play an important role. This was reflected in the relatively high levels of RGDcontaining peptides required to inhibit attachment in this study.
Assuming that the cell receptor(s) to which FMDV attaches is (are) necessarily conserved, it follows that the attachment site on the virus is conserved. This appears to be the case, RGD remaining highly conserved despite being in a hypervariable immunogenic region of VP1. It might be expected, therefore, that antiserum to one serotype of FMDV would cross-protect against infection with all other serotypes, by virtue of binding to the conserved attachment site. This, however, is not so because there is little or no cross-protection between serotypes in FMDV. Therefore, if the original supposition is correct, there must be a mechanism of escape from antibodies to this putative common epitope. It is thought that this problem is circumvented in the structurally related human rhinovirus 14 by the attachment site being buried in a cleft on the virus surface, inaccessible to antibody but accessible to the cell receptor (Rossmann et al., 1985) . This does not appear to be the solution with FMDV however, as enzyme cleavage studies of the virus (Strohmaier et al., 1982) and the mapping of neutralizing monoclonal antibodies (Parry et al., 1985) have shown the putative attachment site to be highly accessible. Studies with neutralizing monoclonal antibodies and anti-peptide antibodies to short sequences containing RGD, which also neutralize the virus (F. Brown, unpublished results), refute two other possible explanations; first, for reasons of size or conformation, the attachment site is a poor immunogen and second, that it is not recognized as foreign because it is present in a variety of host proteins. We feel that the most likely explanation is that antibody footprints in this region include some sequence surrounding RGD, and the variation in this sequence is sufficient to prevent binding of antibodies to the RGD region of another serotype, hence accounting for the lack of crossprotection.
The evidence presented here implicates the tripeptide sequence RGD in the attachment of FMDV to BHK cells. It is clear that there is also a contribution from the C-terminal region of VPI, and it is probable that other factors are involved. This report represents a first step in the understanding of the structure of the FMDV attachment site.
Note added inproof The structure of FMDV has recently been solved by X-ray crystallography at close to atomic resolution [Acharya et al. (1989) Nature, London (in press)]. It reveals both the 14(~ 160 region and the C terminus of VPI to be exposed on the surface of the virus and confirms their proximity. There is no evidence to support surface depressions equivalent to the clefts found in human rhinovirus 14.
